Company / Shareholders' Equity
Inhibrx Biosciences, Inc. Shareholders' Equity History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$8.0M
FY2025
5-year range
$8.0M / $43.5M
FY2023-FY2025
Trend
-81.6%
vs FY2024
Sector context
#190 of 213
Health Care
What the data says
Inhibrx Biosciences, Inc.'s shareholders' equity of $8M is lower than 89% of companies in the Health Care sector (FY2025). Declined from $44M to $8M over the past 2 years.
Based on SEC 10-K filings.
$8M in FY2025.
Declined from $44M to $8M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 11% in Health CareTop 89% of 213This company $8.0M Sector average $2.5B
▼
-99.7% below sector average
Key checks
Key Insights
- In FY2025, shareholders' equity decreased 81.6% year-over-year.
- Ranks #190 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -3.77 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.0M | -81.6% |
| FY2024 | $43.5M | +0.0% |
| FY2023 | $43.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026